inner thigh glp 1 injection ✨ How to Inject Your GLP-1 Medications ✨ , In this video, we’re walking you through how to safely inject yourself with our GLP-1 medications like Semaglutide and Tirzepatide. , Here’s what you need to What to Know about GLP-1

launched July 1, 2026 through December 31, 2027 Who Faces the Greatest Need for This Coverage The groups most likely to benefit from the Medicare GLP-1 Bridge program include: Medicare Part D enrollees ages 65 and older with a body mass index of 35 or higher, or a BMI of 27 or higher combined with a qualifying condition such as cardiovascular disease or prediabetes Adults with obesity who were previously unable to afford brand-name GLP-1 medications on fixed retirement incomes People who discontinued brand-name GLP-1 treatment due to cost and are eligible to re-enter with the $50 Bridge copay Patients managing obesity-related conditions including hypertension, sleep apnea, and prediabetes, who may reduce downstream healthcare costs through weight management People who already receive GLP-1 coverage through their Part D plan for diabetes, cardiovascular disease, or sleep apnea do not qualify for the Bridge program they continue to access the drugs through their existing coverage

This program was created with the following key considerations in mind: Lean Protein Insufficient protein intake can lead to excessive loss of lean body mass, weakness, oedema, hair loss, and skin changes

Christopoulos A

By incorporating simple habits like letting the medication reach room temperature and rotating your injection sites, you can virtually eliminate discomfort

Conclusions When considered collectively, GLP-1 RAs demonstrate significant potential for the treatment of age-related conditions and the extension of lifespan